Transplant Service Documentation Requirements
Customize your policy alerts
Sign up for Arizona Complete Health Policy CP.MP.247 alerts
Get alerted when Policy CP.MP.247 changes without checking for updates manually.
Monitor payer policy activity
Defines required clinical documentation and testing for transplant evaluation, listing, and post-transplant follow-up for solid organ and stem cell/bone marrow transplants; applies to providers submitting prior authorization requests to the health plan.
No material clinical or coverage changes in this revision.
Coverage Criteria and Required Documentation
Documentation and testing criteria for evaluation and listing
Covered when ALL of the following documentation elements are provided for transplant evaluation, listing, or post-transplant follow-up as specified:
Approved evaluation requests effective for 6 months
Approved listings effective for 12 months
See policy for organ-specific details
See policy for specifics
Applies to solid organ and stem cell as specified
Post-transplant follow-up
Post-transplant follow-up visits are covered when ALL of the following are provided:
Separate authorization required for services unrelated to post-transplant follow-up
Continuity of care listing
Continuity of care listing authorizations are considered medically necessary when ALL of the following are provided:
Used for continuity transfers
Additional/multiple facility authorizations
Additional authorizations for transplant services at multiple facilities or additional evaluations are considered medically necessary when ANY of the following are met:
Applies when prior approval already rendered
Applies when prior approval already rendered
This policy does not address requests for corneal transplant, pancreatic islet cell auto-transplant after pancreatectomy, or parathyroid auto‑transplant after thyroidectomy. Requests for these procedures require completion of the Health Plan–specific prior authorization form available on the Health Plan website and are handled separately from the solid organ and stem cell transplant documentation requirements described in this policy.
Coverage determinations using this clinical policy are a guide to medical necessity and do not replace the member’s coverage documents. All coverage is subject to the terms, conditions, exclusions, and limitations of the member’s applicable coverage documents (for example, evidence of coverage, certificate of coverage, policy, or contract). The Health Plan’s administrative rules, state or federal requirements, and contract language govern final benefit determination.
Timing Windows and Coding-related Timeframes
Provider Responsibilities and Prior Authorization
Prior Authorization Required
Prior authorization is required for transplant evaluation, transplant listing, and post‑transplant follow‑up visits. Inpatient transplant admissions require a separate authorization from evaluation/listing or post‑transplant visit authorizations.
- Submit a prior authorization request using the Health Plan–specific prior authorization form available on the Health Plan website (required for corneal transplant, pancreatic islet cell auto‑transplant after pancreatectomy, parathyroid auto‑transplant after thyroidectomy, and all transplant evaluation/listing/post‑transplant follow‑up requests).
- Approved listings are effective for 12 months; after 12 months a new authorization with updated clinical documentation is required.
- Inpatient transplant admissions require separate authorization.
Use of Policy for Prior Authorization
Use this clinical policy as a guide to assist with prior authorization and coverage decisions, but verify member coverage, benefits, and any plan‑level rules before submitting requests. Coverage and administration of benefits remain subject to the member's contract, state and federal requirements, and any Health Plan‑level administrative policies.
- This policy does not guarantee payment; confirm member eligibility and benefit details in the Health Plan prior authorization tool or provider portal.
- For Medicaid members, state Medicaid coverage provisions supersede this clinical policy when conflicts exist.
Required Documentation for Evaluation and Listing
Required documentation must be submitted with evaluation or listing prior authorization requests. Missing or incomplete documentation may result in denial or delay of the authorization.
- Appropriate prior authorization form (completed) and, when applicable, Health Plan–specific form for certain transplant types.
- Letter of medical necessity from a transplant service provider with signature (for listing requests).
- Complete history and physical: within 12 months for kidney transplants; within 6 months for other transplants; for evaluation requests, H&P within one year.
- Relevant laboratory testing: complete chemistry panel, LFTs, and CBC within 12 months for kidney transplants or within 6 months for other transplants.
- Organ‑specific testing and imaging as indicated (e.g., INR/MELD/PELD and liver imaging/biopsy for liver; GFR/creatinine clearance for kidney; echocardiogram/right heart cath/NYHA/peak VO2 for heart; PFTs, imaging, and six‑minute walk for lung; insulin treatment history for pancreas; failed TPN documentation for intestine/multivisceral).
- Stem cell specific: most recent bone marrow biopsy as indicated, ECOG or Karnofsky score, lumbar puncture if indicated, and donor identification for allogeneic transplants.
- Infectious disease screening and vaccine/serology documentation per policy (CMV, VZV, EBV, Hepatitis B and C, RPR, HIV, PPD/T‑Spot/QuantiFERON) with timing and follow‑up viral load or CD4 when baseline positive.
- Serum or urine drug screen within 90 days.
- Annual dental evaluation/clearance, routine health screening exams, cardiology testing/clearance, comorbidity testing/clearance, and detailed psychosocial evaluation (timing: 12 months for kidney, 6 months for other transplants).
Documentation and Regulatory Alignment
Providers must follow documentation standards and review applicable Medicare National Coverage Determinations (NCDs), Local Coverage Determinations (LCDs), and Medicare Coverage Articles where Medicare rules apply. Ensure submitted documentation aligns with Health Plan requirements and any applicable regulatory or contractual obligations.
- For Medicare members, review all applicable NCDs, LCDs, and Medicare Coverage Articles on the CMS website prior to applying this clinical policy.
- Documentation must support medical necessity and meet the timing and content specifications in this policy (e.g., H&P and testing timeframes).
- Where state Medicaid rules conflict with this policy, state Medicaid provisions take precedence.
Candidate Evaluation and Eligibility
Candidate evaluation
Clinical evaluation should assess disease stage, comorbidities, functional status, and infection history; for stem cell transplants include disease-specific assessments and performance status.
Use ECOG or Karnofsky performance status for HCT candidacy; consider EBMT and HCT-CI scoring for allogeneic HCT
Evaluate functional status and comorbidities per institutional standards
Conditions that would complicate surgery or negatively affect postoperative recovery are relevant to medical necessity determinations for transplant evaluation and listing. The pre‑transplant assessment exists to identify such factors — including significant comorbidities, active uncontrolled infection, or other medical issues — that may render a patient unsuitable for transplant or require optimization prior to listing. Although the policy does not list explicit absolute contraindications, clinical evidence of factors that increase surgical risk or impair recovery should be documented and will influence approval decisions.
Evaluation Requirements and Pre-transplant Testing
Evaluation requirements: H&P, organ testing, infectious screening, psychosocial, dental
Complete evaluation documentation must include a history and physical, organ-specific testing, infectious disease screening, psychosocial evaluation, annual dental evaluation/clearance, cardiology clearance as indicated, routine health screening, and a serum/urine drug screen within 90 days of the request.
- History and physical (H&P) — within 12 months for kidney, within 6 months for other transplants
- Organ-specific testing (e.g., INR/MELD for liver; GFR for kidney; echo and right heart cath for heart; PFTs and 6-minute walk for lung; TPN failure documentation for intestine; bone marrow biopsy and ECOG/Karnofsky for stem cell)
- Infectious disease screening (CMV, VZV, EBV, TB testing, Hep B/C, RPR, HIV) with timing per policy
- Detailed psychosocial evaluation — within 12 months for kidney, within 6 months for other transplants
- Annual dental evaluation/clearance and drug screen within 90 days
Transplant Center and Admission Requirements
Center and admission requirements: separate prior authorization and credentialing expectations
Transplant inpatient admissions and requests for services at multiple facilities require separate prior authorization per Health Plan guidelines; transplant program credentialing/authorization expectations and applicable standards (e.g., FACT/JACIE) should be considered.
- Inpatient transplant admissions require a separate authorization from evaluation/listing or post-transplant follow-up authorizations
- Additional facility authorizations may be medically necessary if member's clinical status changes or if admitted to a closer facility and not stable for transfer
Post-Transplant Outpatient Follow-up
Background and Rationale
The goal of the pre‑transplant evaluation is to identify conditions that can affect transplant success and to determine candidacy. Evaluation should assess comorbidities, overall disease stage and organ function, prior or active infection history, and functional status using appropriate performance scales. These elements guide whether a patient is a suitable candidate for transplantation and what additional testing, optimization, or clearances (for example cardiology, infectious disease, dental, or psychosocial) are required before listing.
Definitions and Scoring Systems
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.